【参考文献】
[1]DAMIER P, HIRSCH E C, AGID Y, et al. The substantia nigra of the human brain. Ⅱ. Patterns of loss of dopamine?containing neurons in Parkinson’s disease[J]. Brain, 1999,122(Pt 8):1437?1448.
[2]GRANT R J, CLARKE P B. Susceptibility of ascending dopamine projections to 6?hydroxydopamine in rats: effect of hypothermia[J]. Neuroscience, 2002,115:1281?1294.
[3]李林静,姜宏,王俊,等. GHRELIN对MPTP小鼠帕金森病模型黑质TH、BCL?2和BAX mRNA表达的影响[J]. 青岛大学医学院学报, 2007,43(4):283?285.
[4]周晓彬,纪新强,徐莉. 医用统计学软件PPMS 1.5的组成和应用特点[J]. 齐鲁医学杂志， 2009,24(1):29?32.
[5]GRIFFITHS P D, DOBSON B R, JONES G R, et al. Iron in the basal ganglia in Parkinson’s disease. An in vitro studyusing extended X?ray absorption fine structure and cryo?electron microscopy[J]. Brain, 1999,122:667?673.
[6]YOUDIM M B H, RIEDERER P. Is Parkinson’s disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeration[J]? Acta Neuro Scand, 1989,126:47?54.
[7]VENARUCCI D, VENARUCCI V, VALLESE A, et al. Free radicals: important cause of pathologies refer to aging[J]. Panminerva Med, 1999,414:335?339.
[8]CASTELLANI R J, SIEDLAK S L, PERRY G, et al. Sequestration of iron by Lewy bodies in Parkinson’s disease[J]. Acta Neuropathologica, 2000,100:111?114.
[9]OSTREROVA?GOLTS N, PETRUCELLI L, HARDY J, et al. The A53T alpha?synuclein mutation increases iron?dependent aggregation and toxicity[J]. J Neurosci, 2000,20:6048?6054.
[10]姜宏,谢俊霞. 黑质内注射FeCl3对大鼠纹状体多巴胺释放量及含量的影响[J]. 青岛大学医学院学报, 2002,38(2):103?106.
[11]JIANG H, LUAN Z, XIE J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron?overload[J]. Neurochem Int, 2006,49:605?609.
[12]ZHANG S, WANG J, SONG N, et al. Up?regulation of divalent metal transporter 1 is involved in 1?methyl?4?phenylpyridinium (MPP(+))?induced apoptosis in MES 23.5 cells[J]. Neurobiol Aging, 2009,30:1466?1476.